Across TCGA pan-cancer cohorts, DEFB134 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated DEFB134 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher DEFB134 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DEFB134 expression acts as an unfavorable survival marker.

SKCM are the cancer types where DEFB134 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.023	0.738	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: DEFB134 tumor-vs-normal RNA expression · all DEFB134 data types